Akèy › Maladi fwa › Utah
Etid klinik pou Maladi fwa nan Utah
6 etid pou Maladi fwa ap chèche patisipan nan sit nan Utah.
Vil nan Utah
Tèks ofisyèl etid la (Anglè)
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
- 89bio Clinical Study Site, Sandy City
- 89bio Clinical Study Site, West Jordan
Ap rekriteFaz 3
Laj 18 a 75 · Tout sèks · Mizajou Sep 3, 2026 · NCT06419374A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
- 89bio Clinical Study Site, Ogden
Ap rekriteFaz 3
Laj 18 a 80 · Tout sèks · Mizajou Sep 3, 2026 · NCT06318169Primary Sclerosing Cholangitis in Children
- The University of Utah, Salt Lake City
Ap rekriteEtid obsèvasyon
Laj 2 a 25 · Tout sèks · Mizajou Jul 14, 2026 · NCT04181138A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)
- Intermountain Health, Salt Lake City
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Dec 15, 2025 · NCT06619561Liver Transplantation in Patients With CirrHosis and Severe Acute-on-Chronic Liver Failure: iNdications and outComEs
- University of Utah Health, Salt Lake City
Ap rekriteEtid obsèvasyon
Laj 18 a 80 · Tout sèks · Mizajou Oct 20, 2025 · NCT04613921Long-Term SafEty and Clinical Outcomes of LivmArli in Patients in the United States (LEAP-US)
- University of Utah, Division of Pediatric Gastroenterology, Hepatology and Nutrition, Salt Lake City
Ap rekriteEtid obsèvasyon
Tout laj · Tout sèks · Mizajou May 25, 2025 · NCT06193928Sous ClinicalTrials.gov, done yo ranmase Oct 2, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.